UPDATE 1-Intuitive Surgical profit beats Wall Street estimates
UPDATE 1-Intuitive Surgical profit beats Wall Street estimates
By Deena Beasley
July 20 (Reuters) - Intuitive Surgical Inc (ISRG.O) on Thursday reported a higher-than-expected second-quarter profit, citing increased sales of its da Vinci surgical robots.
Intuitive said it now expects 2017 procedure growth of 14-15 percent, up from its prior view of 12-14 percent, but it continues to expect selling prices to moderate as it sells more systems to "cost-sensitive markets" and offers discounts for multiple-unit deals.
The company's shares, which rose 5 percent to close at $971.73 in regular Nasdaq trading, were down 1.7 percent at $970 after hours.
Excluding items, Intuitive said it earned $228 million, or $5.95 per share, which beat the average Wall Street estimate of $5.79 per share as compiled by Thomson Reuters I/B/E/S.
Revenue totaled $756 million, up 13 percent from a year earlier, driven by growth in recurring instrument, accessory, and service revenue, and higher systems revenue.
The company said it shipped 166 da Vinci Surgical Systems in the second quarter, compared with 130 in the second quarter of 2016.
Quarterly net income totaled $222 million, or $5.77 per share, compared with $185 million, or $4.71 per share, due in part to a new 2017 accounting standard requiring that $30.6 million, or 80 cents per share, of excess tax benefits related to employee share-based compensation awards be recorded as a component of income tax expense.
By Deena Beasley
作者：蒂娜·比斯利
July 20 (Reuters) - Intuitive Surgical Inc (ISRG.O) on Thursday reported a higher-than-expected second-quarter profit, citing increased sales of its da Vinci surgical robots.
路透7月20日電-直覺外科公司公司週四公佈第二季度利潤高於預期，原因是達·芬奇手術機器人銷量增加。
Intuitive said it now expects 2017 procedure growth of 14-15 percent, up from its prior view of 12-14 percent, but it continues to expect selling prices to moderate as it sells more systems to "cost-sensitive markets" and offers discounts for multiple-unit deals.
直覺表示，目前預計2017年流程增長14%-15%，高於之前12%-14%的預期，但該公司繼續預計銷售價格將放緩，因為它向“成本敏感市場”銷售更多系統，併為多單元交易提供折扣。
The company's shares, which rose 5 percent to close at $971.73 in regular Nasdaq trading, were down 1.7 percent at $970 after hours.
在納斯達克的常規交易中，該公司的股價上漲了5%，收於971.73美元，而盤後則下跌了1.7%，收於970美元。
Excluding items, Intuitive said it earned $228 million, or $5.95 per share, which beat the average Wall Street estimate of $5.79 per share as compiled by Thomson Reuters I/B/E/S.
剔除項目後，直覺表示盈利2.28億美元，合每股5.95美元，超過了湯森路透I/B/E/S編制的華爾街平均預期5.79美元。
Revenue totaled $756 million, up 13 percent from a year earlier, driven by growth in recurring instrument, accessory, and service revenue, and higher systems revenue.
收入總計7.56億美元，同比增長13%，這得益於經常性儀器、配件和服務收入的增長，以及系統收入的增加。
The company said it shipped 166 da Vinci Surgical Systems in the second quarter, compared with 130 in the second quarter of 2016.
該公司表示，第二季度出貨量為166臺達芬奇外科系統，而2016年第二季度為130台。
Quarterly net income totaled $222 million, or $5.77 per share, compared with $185 million, or $4.71 per share, due in part to a new 2017 accounting standard requiring that $30.6 million, or 80 cents per share, of excess tax benefits related to employee share-based compensation awards be recorded as a component of income tax expense.
季度淨收入總計2.22億美元，合每股5.77美元，而去年同期為1.85億美元，合每股4.71美元，部分原因是2017年的新會計準則要求，與基於員工股份的薪酬獎勵相關的3060萬美元，合每股80美分的超額税收優惠，應記錄為所得税支出的一部分。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧